Pfizer PFE EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pfizer's EPS (diluted)?
- Pfizer (PFE) reported EPS (diluted) of $0.47 in Q1 2026.
- How has Pfizer's EPS (diluted) changed year-over-year?
- Pfizer's EPS (diluted) decreased by 9.6% year-over-year, from $0.52 to $0.47.
- What is the long-term trend for Pfizer's EPS (diluted)?
- Over 2 years (2021 to 2024), Pfizer's EPS (diluted) has grown at a -39.4% compound annual growth rate (CAGR), from $3.84 to $1.41.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.